03.03.2015
- The US Food and Drug Administration has approved the hormonal intrauterine contraceptive (IUD) Lileta, which releases the hormone levonorgestrel to inhibit thickening of the womb...
29.07.2014
- Over the past five years, emerging markets have experienced some of the highest pharmaceutical market growth rates, a trend that is expected to continue. Central Eastern Europe...
15.07.2014
- Teva Pharmaceutical Industries board is to appoint vice-chairman Amir Elstein as its new chairman, activist shareholder Benny Landa has said. "I was informed by Moshe Many, Amir...
16.05.2014
- Shortly before expiration of the patent on the multiple sclerosis treatment Copaxone, a US district court has dismissed a case by Teva Pharmaceutical Industries, subsidiary of the...
29.04.2014
- Generics producer Actavis has sued the U.S. Food and Drug Administration, challenging its decision to award exclusive rights to Israel's Teva to sell a generic version of Pfizer's...
08.04.2014
- Teva Pharmaceutical Industries, U.S. subsidiary of the Israeli generics drugmaker, has asked the U.S. Supreme Court to stop a lower court ruling from going into effect while the...
01.04.2014
- The U.S. Supreme Court on Mar. 31 agreed to hear an appeal filed by Teva Pharmaceutical Industries in a patent fight over top-selling multiple sclerosis drug Copaxone. The move...
21.02.2014
- Dublin, Ireland-based generic drugmaker Actavis is acquiring specialty pharmaceuticals company Forest Laboratories of New York in a cash and stock deal valued at about $25 billion...
